This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
New evidence supports the idea that differences within and between sexes impact how neurological disorders progress and respond to treatment. The findings were presented at Neuroscience 2026, the annual meeting of the Society for Neuroscience.
Scientists are discovering that some disorders behave differently depending on a person's biological sex and genetic risk factors. These differences offer the potential for customized treatment based on an individual's biological and genetic profile. Two such conditions are Alzheimer's disease (AD) and fibromyalgia, a chronic condition characterized by pain and fatigue experienced by 2% to 4% of the global population.
AD is an incurable brain disorder that leads to progressive memory loss and declining brain function; it affects between 35 and 40 million people across the world, according to the World Health Organization.
"These four studies illustrate the fascinating discoveries that can be made when focusing on female-specific biology or possible sex differences in AD-related symptoms and risk factors," said Liisa Galea, Treliving Family chair in Women's Mental Health at Center for Addiction and Mental Health and moderator of the press conference.
"The research presented at Neuroscience 2026 helps us pinpoint the specific differences that may help us develop more targeted treatment using precision approaches, even for some of our most complex brain disorders."
Source link







